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Abstract
Chemokines and chemokine receptor-mediated effects are important mediators of the immunological response and cure in
human leishmaniasis. However, in addition to their signalling properties for leukocytes, many chemokines have also been
shown to act directly as antimicrobial peptides on bacteria and fungi. We screened ten human chemokines (CXCL2, CXCL6,
CXCL8, CXCL9, CXCL10, CCL2, CCL3, CCL20, CCL27, CCL28) for antimicrobial effects on the promastigote form of the
protozoan parasite Leishmania mexicana, and observed direct parasiticidal effects of several, CCL28 being the most potent.
Damage to the plasma membrane integrity could be visualised by entrance of propidium iodide, as measured with flow
cytometry, and by scanning electron microscopy, which showed morphological changes and aggregation of cells. The
findings were in concordance with parasiticidal activity, measured by decreased mitochondrial activity in an MTT-assay. This
is the first report of direct antimicrobial activity by chemokines on parasites. This component of immunity against
Leishmania parasites identified here warrants further investigation that might lead to new insight in the mechanisms of
human infection and/or new therapeutic approaches.
Citation: So¨birk SK, Mo¨rgelin M, Egesten A, Bates P, Shannon O, et al. (2013) Human Chemokines as Antimicrobial Peptides with Direct Parasiticidal Effect on
Leishmania mexicana In Vitro. PLoS ONE 8(3): e58129. doi:10.1371/journal.pone.0058129
Editor: Paul Proost, University of Leuven, Rega Institute, Belgium
Received June 29, 2012; Accepted February 1, 2013; Published March 22, 2013
Copyright:  2013 So¨birk et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: SS and MC are supported by Swedish governmental funding for clinical research (ALF). MC is supported by grants from the Swedish Research Council
(2010-57X-20240), the Foundations of Wiberg, Kock, Bergvall, O¨sterlund, Hedberg, Hedlund, Groschinsky, So¨derberg, the Swedish Society for Medicine, the Royal
Physiograc Society, King Gustaf Vs Memorial Fund, the Medical Faculty at Lund University, and Hansa Medical AB. The funders had no role in preparation of the
manuscript or decision to publish.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: sara.karlsson_sobirk@med.lu.se
Introduction
Cutaneous, mucocutaneous and visceral leishmaniasis in hu-
mans are caused by several species of the intracellular protozoan
parasite Leishmania. The clinical picture and outcome of disease
depends on the particular Leishmania species that causes infection,
immunological status, and possibly also genetic factors of the host.
When the promastigote form of the parasite enters the
haemorrhagic pool caused by the bite of an infected sand fly, it
is rapidly taken up by dermal macrophages, neutrophils and other
antigen presenting cells. Within macrophages, the promastigote
transforms to the smaller amastigote form, which multiplies in the
phagosome/parasitophorous vacuole of the macrophage. When
the macrophage eventually ruptures, the amastigotes can be taken
up by other macrophages and continue to divide. Throughout its
life cycle, the Leishmania parasite has to withstand the immune
systems of both vector and host long enough to secure further
transmission through the next bite. It has therefore evolved
different ways to modulate the immune response of the
mammalian host outside and within the hostile environment of
the phagosomes of macrophages.
In order for the host to clear infection, a cellular immune
response is required, where a majority of the Leishmania-specific
CD4+ T-cells differentiate into T helper (Th) 1-cells. The Th1-
cells secrete IFN-c, TNF-a, activate macrophages, and are
important for parasite elimination. Many chemokines (CCL2,
CCL3, CXCL8, CXCL9, CXCL10) are important as chemotactic
agents and through their activation of different types of leukocytes
in leishmaniasis [1]. There is also evidence that certain
chemokines (CCL3, CCL4, CCL5, MCAF) are antiparasitic and
increase phagocytosis and NO-mediated killing of different
protozoa, but to date such effects have been attributed to indirect
activity on the macrophages and not to a possible direct effect on
the parasites [2,3,4,5].
Infection with Leishmania parasites alters expression of chemo-
kines and chemokine receptors in the host [6,7]. Leishmania major
has been shown to up-regulate genes for IL-8, CXCL2,
CXCL3,CCL20 and down-regulate CXCL9, CXCL10 and
CCL2 in human macrophages in vitro [7], possibly part of an
immune evasion response. Conversely, in skin lesions taken from
patients with localised (typically self-healing) cutaneous leishman-
iasis, CXCL9, CXCL10 and CCL2 are highly expressed, and
CCL3 is only present in low levels, this response perhaps being
part of an effective immune response. Supporting this idea, in the
more chronic and severe diffuse forms of cutaneous leishmaniasis,
the former chemokines are expressed in low levels, and there are
high amounts of CCL3 [8,9]. These and other data imply that
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chemokines are important players in immunity against Leishmania
parasites.
Antimicrobial peptides (AMPs) and chemokines have many
properties in common; they are small, cationic proteins, and both
groups are believed to be important components of the innate
immunity in a wide range of species. They are usually expressed in
low levels, but up-regulated in response to infectious or in-
flammatory stimuli [10]. The AMPs in the groups of a- and b-
defensins are chemotactic for leukocytes. b-defensins share their
receptor, CCR6, with the chemokine CCL20, which has also been
shown to have direct antimicrobial activity [11,12]. A number of
chemokines have, in addition to their different effects on human
cells, been shown to have antimicrobial activities on bacteria and
fungi (Table 1), and sometimes the term kinocidins is used for
these molecules [13,14,15]. Further, several AMPs from various
species are reported to have effects on different Leishmania species
[16]. The virulence factor Gp63, a multifunctional metallopro-
tease prominent on the surface of promastigotes, also protects
against antimicrobial peptide-induced killing of Leishmania major
[17].
To our knowledge, there are no previous reports of chemokines
having direct antimicrobial effects on parasites, independent of the
activation of leukocytes. As several chemokines have previously
been shown to exhibit antimicrobial effects on both bacteria and
the eukaryote Candida albicans, our aim was to screen the most
probable candidates for possible effects on a protozoan parasite,
Leishmania mexicana. For this study, we chose chemokines previously
tested for antimicrobial effect, some of which had also been shown
to be up or down regulated in leishmaniasis, and here we present
the evidence for antiparasitic activity of several of them.
Results
Several Chemokines Decrease the Mitochondrial Activity
of L. mexicana
Cytotoxicity was measured in an MTT-based assay, in which
viable actively respiring cells with functional mitochondria convert
3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide
(MTT) to purple formazan, measured in a spectrophotometer.
This method, which has been previously validated for Leishmania
parasites in both HBSS and sorbitol buffer systems [18,19], and in
our settings (Fig. S1), gives a measure of viable cells, but not the
mechanism of the cytotoxic effect. In three identical independent
experiments, cytotoxic activity was observed for several of the
chemokines that have previously shown antibacterial and antifun-
gal properties (Fig. 1). CXCL6, CXCL9 and CCL28 were the
most effective causing over 80% loss of viability, but substantial
decrease of mitochondrial activity (over 50%) was also observed
for CXCL2, CXCL10, and CCL20 (Table 2). Dose-response
assays were carried out for CXCL9 and CCL28, which showed
a dose-dependent activity for both (Fig. 2). CCL3 exerted
a marginal effect, whereas CXCL8, CCL2 and CCL27 did not
cause a statistically significant decrease in viability. These findings
were in concordance with pilot studies in which cells were
manually counted in a Neubauer chamber on days 0–3 after
incubation with the chemokines, corresponding well to survival of
cells on day 3 (Table S1). The most effective chemokines had an
activity comparable to that of Amphotericin B, a currently
deployed first-line antileishmanial drug that acts by forming pores
in the surface membrane. Additional assays, also performed in
sorbitol buffer with serum, or in HBSS (Hanks Balanced Salt
Solution) with or without serum did not show the same activity as
when performed in sorbitol buffer alone (Fig. S2, S3), but point
toward a possible effect in HBSS with serum.
Chemokines Make Leishmanial Membranes Permeable to
Vital Dyes
Membrane integrity can be assessed by the entry of vital dyes,
and entry of propidium iodide (PI) has previously been used to
study membrane damage in Leishmania.
Flow cytometry was used to detect entrance of PI and after 4
hours of incubation, the plasma membranes of L. mexicana
promastigotes were sufficiently permeabilized by several of the
chemokines to allow entrance of PI (Fig. 3), a molecule of relative
molecular mass 668 Da. Flow cytometry dot plots of cell
morphology (forward scatter versus side scatter) revealed that the
chemokines did generate some, but not gross morphology changes
in the cells (Fig. 3B–E). With few exceptions, the chemokines
yielding the highest percentage of PI-positive cells also showed the
largest decrease in mitochondrial function in the MTT-assay,
Table 1. Chemokines used in this study and previous reports of their antimicrobial activity.
Chemokine new/old name Main leukocyte targets Antimicrobial activity Calculated pI
CXCL2/GRO-b Neutr, Mo, Mast E. coli, S. aureus [12] 10.27
CXCL6/GCP-2 Neutr, Mo, Mast S. pyogenes, S. aureus, E. coli, P. aeruginosa,
S. dysgalactiae [26]
9.06
CXCL8/IL-8 Neutr, Mo, Mast S. aureus, S. typhimurium, C. albicans [13] 8.97
CXCL9/MIG Th1, NK, pDC, Mast E. coli, S. aureus, S. pyogenes, N. gonorrhoeae [12] 10.83
CXCL10/IP-10 Th1, NK, pDC, Mast E. coli, S. aureus [12] 10.52
CCL2/MCP-1 Mo, Bas, MemT No activity on E. coli, S. aureus [12] 9.58
CCL3/MIP-1a mDC, Mo, MemT, Th1, Treg, NK, pDC No activity on E. coli, S. aureus [12] 4.60
CCL20/MIP-3a BC, mDC, MemT E. coli, S. aureus, C. albicans [12] 10.08
CCL27/CTACK MemT C. albicans. No activity on E. coli, S. aureus [12,27] 9.11
CCL28/MEC MemT S.pyogenes, S.aureus, E.coli, C.albicans [27] 10.23
Chemokines are listed with their systematic/common names, main leukocyte targets [23] and antimicrobial activity previously reported. Bas, basophils;BC, B-cells; Mast,
mast cells; mDC, myeloid dendritic cells; MemT, memory T-cells; Mo, macrophages; NK, natural killer cells; Neut, Neutrophils; pDC, plasmacytoid dendritic cells; Th1, T-
helper 1 cells. Calculated pI may be important, as the cationic properties of the peptides, at least in part, may explain the interaction with the plasma membrane and the
antimicrobial activity. Theoretical pI for CCL28 was computed using the EXPASy primary structure analysis tool, others taken from Yang et al. 2003 and Svensson et al.
2010 [12,28].
doi:10.1371/journal.pone.0058129.t001
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indicating membrane damage as a likely cause of the cytotoxic
activity of the chemokines (Table 2).
Chemokines Cause Aggregation of Promastigote Cells
When promastigotes were incubated with 10 mM of the
chemokines in 1.5 mL tubes, an immediate aggregation of cells
Figure 1. Cytotoxic activity of chemokines against Leishmania promastigotes. Reduction of mitochondrial activity in the MTT assay, as
a measure of cytotoxic activity of the chemokines on the promastigotes after 4 hrs of incubation with 10 mM of the chemokines or 5 mM of
Amphotericin B. The MTT assay was performed in three independent experiments on different days, and each incubation performed in triplicate.
Horizontal lines represent mean values of individual measurements and are expressed as percentages of negative controls. P-values (for significant
difference to negative control) were calculated using the Wilcoxon Rank-Sum test, adjusted with the Hochberg procedure for multiple comparisons.
doi:10.1371/journal.pone.0058129.g001
Table 2. Overview of observed activity on the promastigotes by the chemokines.
Chemokine Cytotoxic activity Membrane damage Aggregation of cells Morphologic change in SEM
CXCL2 ++ ++ + +
CXCL6 +++ +++ + +
CXCL8 2 2 2 N.D.
CXCL9 +++ ++ 2 +
CXCL10 ++ ++ 2 2
CCL2 2 2 2 +
CCL3 2 2 2 N.D.
CCL20 ++ + ++ +
CCL27 2 2 + +
CCL28 +++ ++ +++ +
Amph.B +++ ++ 2 +
Cytotoxic activity in the MTT-assay (quantified – to +++), membrane damage measured by entry of PI in flow cytometry (quantified – to +++), aggregation of cells
observed by the eye and in light microscopy (semiquantified – to +++), and morphologic changes of the cells visible in SEM (- or +) are summarized. N.D. = not done.
doi:10.1371/journal.pone.0058129.t002
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was visible for many of the chemokines. The aggregation of cells
could be observed by the eye, and in light microscopy, where
apparently intact cells were clumped together with morphologi-
cally altered cells and cell debris. Not all chemokines caused
aggregation, and the degree of aggregation varied among those
that did (CXCL2, CXCL6, CCL20, CCL27, CCL28; Table 2).
Chemokines Cause Morphological Changes by Scanning
Electron Microscopy (SEM)
Previous studies have shown morphological changes of Leish-
mania promastigotes when treated with AMPs [17]. Electron
microscopy has been used for Leishmania and other protozoan
parasites to visualize cell surface alterations, cell shrinkage, and
changes of cytoskeleton as an effect of antiparasitic chemotherapy
[20]. In order to see if the chemokines used in our screen were
Figure 2. Dose-response of CXCL9 and CCL28 on promastigotes. Reduction of mitochondrial activity in the MTT-assay, as a measure of
cytotoxic activity of CXCL9 and CCL28 on the promastigotes after 4 hrs of incubation with the chemokines in concentrations from 25 to 0.16 mM,
with CCL3 for comparison, all assayed against negative controls. A dose-dependent response can be seen between 15 and 1,25 mM for both CXCL9
and CCL28.
doi:10.1371/journal.pone.0058129.g002
Figure 3. Damage to the promastigote surface membrane visualised by flow cytometry. PI-signal in flow cytometry, after incubation with
chemokines, positive cells as a percentage of gated cells (A). Plots showing side scatter (y-axis) and forward scatter (x-axis) of untreated promastigote
cells (B), and cells treated with Amphotericin B (C), CXCL9 (D) and CCL28 (E). Scatter plots (B-E) represent the whole population of (ungated) cells.
doi:10.1371/journal.pone.0058129.g003
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inducing morphological changes, and in order to visualise the
aggregations observed, SEM was used to examine the chemokine-
treated promastigotes. In SEM (Fig. 4), promastigotes showed
different degrees of morphological changes. Many cells exhibited
shrinking/rounding up responses in a similar way as is seen after
treatment with Amphotericin B, itself known to act on plasma
membranes. This type of morphological effect on Leishmania
promastigotes has previously been shown for antimicrobial
peptides [17].
The aggregations which were visible macroscopically within
seconds of incubating the parasite with some of the peptides were
also visible in SEM for most of the chemokine-treated parasites
(CXCL2, CXCL6, CCL20, CCL28). Aggregations of apparently
intact and broken promastigotes were visible, sometimes with
a matrix or fibrillar network of possible cytoplasmic or nuclear
contents.
Parasiticidal Chemokine CCL28 is not Cytotoxic to
Human Cells
One potential concern with membrane active peptides is
cytotoxicity against human cells. We therefore tested one
chemokine (CCL28) with parasiticidal activity against L. mexicana,
and one without such activity (CCL3) for cytotoxicity against
human cells. CCL28 and CCL3 at 10–20 mM were tested in
a whole blood haemolysis assay and a lactate dehydrogenase
(LDH) release assay on cultured keratinocytes as previously
Figure 4. Damage to Leishmania promastigotes visualised by SEM. In scanning electron microscopy, untreated parasites retain their
elongated and fusiform shape (A), whereas treatment with amphotericin B, known to act on plasma membranes, causes the promastigotes to round
up and become smaller (B). This effect was also visible to varying degrees on promastigotes treated with many of the chemokines, here shown for
CXCL9 (C), CCL20 (D), CCL27 (E) and CCL28 (F). Several of the chemokines caused aggregation when incubated with the parasites, here shown for
CCL20 (D) and CCL28 (F), as was visible immediately after adding the chemokines when the incubation was made in 1.5 mL tubes (data not shown).
doi:10.1371/journal.pone.0058129.g004
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described for other antimicrobial peptides [21]. This revealed that
no haemolysis was caused by CCL3, or CCL28 at concentrations
of 10–20 mM, and very little LDH-release from the keratinocytes
could be detected (Fig. 5). When HaCaT keratinocytes were
incubated with 10 mM, a concentration shown above to be
parasiticidal to the L.mexicana promastigotes, the LDH-release
from HaCaT keratinocytes was less than 5% of the positive
control.
Discussion
Leishmaniasis is a major health problem in tropical and
subtropical regions throughout the world. The clinical pre-
sentation ranges from self-healing cutaneous ulcers to systemic
disease affecting internal organs, leading to death if left untreated.
Treatment with the limited number of drugs available against
leishmaniasis is lengthy, costly, and frequently has side effects with
considerable morbidity and risks, and healing (with or without
treatment) requires an appropriate immune response evoked by
the host, in which chemokines are likely to play an important part.
Our results indicate a direct parasiticidal effect of several
chemokines on promastigotes of Leishmania mexicana.
AMPs are known to act in different ways on Leishmania parasites,
either directly on plasma membranes, causing lysis, or through
receptor-mediated disturbance of intracellular signalling events,
sometimes leading to apoptosis [16]. There is a possibility that
chemokines also use such ways to exert their action on
promastigotes of Leishmania mexicana (Table 2). CCL28 caused
substantial plasma membrane damage, which could explain why it
was the chemokine which, in our screen, had the highest cytotoxic
activity. As aggregation of cells was observed for most of the
samples which also showed plasma membrane damage, and the
clumps in SEM and light microscopy seemed to contain cell
debris, a likely explanation is that lysis of the cells released
cytoplasmic contents (e.g. DNA) which caused aggregation of the
cells that were still intact.
CXCL9, which was also very effective in the MTT assay did
not cause aggregation of cells. In preliminary experiments, in
which the cells were manually counted on days 0–3 after
incubation of CXCL9, the cells initially seemed intact, but were
not viable, and decreased rapidly in number from day 0–3, in
comparison to negative control (Table S1). CXCL9 may either
cause smaller breaches in the plasma membrane, large enough
to eventually kill the cell, but smaller than to allow immediate
lysis, or it may exert its action through another mechanism, e.g.
through induction of apoptosis. The least active of the
chemokines were CCL3, CCL2, CXCL8 and CCL27. As the
cationic properties of AMPs are considered important for their
antimicrobial activity, the lesser antiparasitic effect of these four
chemokines may partly, but not completely, be explained by the
lower pI of the peptides (Table 1).
The activity of the chemokines was affected by the presence of
higher salt concentrations (HBSS), or in sorbitol buffer with serum
(Fig. S2, S3), but some of the chemokines seem to be effective in
the combination of HBSS and serum. None of these in vitro
conditions can completely accurately mimic the in vivo situation,
although HBSS with serum may be considered to be the best
approximation of the conditions explored. Also, the concentrations
needed for chemotactic activity, as well as the concentrations
found in different body fluids is usually in the nanomolar range,
much lower than the ones used in our study, and in previous
studies of the antibacterial activity of the chemokines [14,15].
However, it should be noted that activity of the chemokines on the
parasites will occur in the specialised microenvironment of the
parasitophorous vacuole, or at the site of release of the
chemokines, and these micro-physiological conditions are not
known.
Although the mechanisms for the action of each chemokine
needs further investigation, our results demonstrate a direct
antimicrobial effect by several chemokines on Leishmania mexicana,
something that has not been shown for parasites before. Previous
studies have shown increased phagoctyosis and NO-mediated
killing of protozoa in the presence of chemokines (CCL2, CCL3
and CCL5) in macrophages [2,3,4,5]. Although our study did not
show cytotoxic activity of CCL2 and CCL3, and has not
investigated the effects on promastigotes of CCL5, it is possible
Figure 5. Cytotoxicity of CCL3 and CCL28 on human cells. Absorbance of haemoglobin release from erythrocytes following exposure to CCL3
and CCL28 is expressed as percent of positive control, 2% Triton X-100 (5A). Cytotoxicity on HaCaT keratinocytes were measured by cell-
permeabilizing effects of CCL3 and CCL28 in the LDH-based TOX-7 kit, and absorbance expressed as percent of positive control, 1% Triton X-100 (5B).
No haemolysis and very little cell-permeabilizing effects of CCL28 on keratinocytes could be seen at the concentrations used for the chemokine
screen on promastigotes (10 mM). Error bars represent the standard errors of the means (n = 3).
doi:10.1371/journal.pone.0058129.g005
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that increased phagocytosis of parasites may not only be explained
by chemokine-induced activation of the macrophage, but also, at
least in part, by direct interaction between the chemokines and
parasites prior to phagocytosis.
As an effective cellular immune response is needed to heal
the Leishmania infection, immunomodulatory drugs are being
evaluated, some of which have improved clinical outcome when
combined with antimonial therapy [22]. Chemokines and
chemokine receptors are also being extensively investigated as
drug targets against autoimmune diseases [23]. Plasmids
encoding CCL27 and CCL28 have, as adjuvants in a vaccine,
increased antigen specific humoral and cellular responses to
Influenza A in mice [24]. An effective prophylactic vaccine
against leishmaniasis has not yet been developed, and new,
better drugs for leishmaniasis are urgently needed. None of the
drugs available will, on its own lead to healing of Leishmania
infection in an immune-compromised host, as healing requires
a cellular immune response to the parasites. An adequate
immune response is facilitated if some of the parasite cells are
dead, which could mean that even if not all parasites are killed,
and perhaps fewer by physiological concentrations of chemo-
kines, there may still be a significant activity on the parasites
important for the cure of leishmaniasis. In that regard, our
results indicate that topically or systemically administered
chemokines, or chemokine-stimulators could be a promising
target for future studies.
Materials and Methods
Culture Procedures
Promastigotes of the strain L. mexicana MHOM/GT/2001/
U1103 [25], were cultured at 27uC in medium M199 (with Hank’s
salts and HEPES; Invitrogen, Lidingo¨, Sweden) supplemented
with 10% foetal calf serum (FCS), 16BME vitamins and 25 mg/
mL of Gentamicin sulphate (all from Sigma-Aldrich, Schnellen-
dorf, Germany).
1 mL from 10 mL cultures were passaged every 7 days to
new 25 mL sterile culture-flasks. Preparations of cells for the
different assays followed the protocol described by Luque-
Ortega et al. [19], with a few modifications. Cell counting was
performed before every experiment, using a Neubauer counting
chamber, and counts were always performed at least twice on
the same cells.
Assay for Antimicrobial Activity
All peptides used were recombinant human chemokines from
PeproTech, London, UK. Amphotericin B (Sigma-Aldrich) was
used as a positive control. Preparations of both the sorbitol buffer
(280 mM D-sorbitol, 4.0 mM Na2HPO4, 1.0 mM KCl, 4.8 mM
NaHCO3, 10 mM D-glucose, adjusted to pH 7.2) and HBSS
(Hanks Balanced Salt Solution, containing 137 mM NaCl, 5.
3 mM KCl, 0.4 mM KH2PO4, 4.2 mMNaHCO3, 0.
4 mMNa2HPO4, pH 7.2, 10 mM D-glucose, adjusted to pH 7.
2), followed protocols described by Luques-Ortega et. al. [19] All
assays were performed on mid-exponential phase promastigote
cultures harvested on day 5, centrifuged in 1,5006g, washed in
sorbitol buffer twice, and resuspended in sorbitol buffer at a final
concentration of 46107 cells/mL. Such cells were incubated at
27uC for 4 hrs in 100 mL reactions containing 10 mM of the
chemokine or 5 mM of Amphotericin B in sorbitol buffer,
alongside control suspensions, before use in downstream analyses.
Antimicrobial activity was measured as decrease in mitochondrial
metabolism in an MTT assay, essentially as described by Luque-
Ortega et al. [19]. Cell death/reduction of mitochondrial activity
(percentage of negative control) was calculated as follows:
1006(ODsample2ODmedium only/ODnegative control2ODmedium only).
The number of viable promastigotes was confirmed to correlate to
the OD in this assay (Fig. S1). Statistical analysis was made using
the Wilcoxon Rank-Sum test. For assays with human serum in
sorbitol buffer and in HBSS, 10% fresh frozen serum from
a healthy volunteer, not heat inactivated, was used (Fig. S2, S3).
Aggregation of Cells
Cells, cultured and washed as described above, were in-
cubated with 10 mM of the chemokines in 120 mL sorbitol
buffer in 1.5 mL tubes. After careful pipetting to mix the
sample, aggregation of cells was observed through the tubes,
held towards a lamp. The incubated cells were also observed in
light microscopy, directly after the incubation. The degree to
which promastigote cells were aggregated were scored as
follows; Not present (-) no change in turbidity, or present in
different degrees (+) aggregation of a minority of parasites, (++)
aggregation of significant proportion of parasites in light
microscopy, and visible aggregation to the eye, but not complete
clearing of the turbidity in the tube, (+++) aggregation of
majority of parasites in light microscopy, and rapid aggregation
to the eye, clearing the liquid from remaining turbidity.
(Table 2).
Flow Cytometry/entrance of Vital Dyes
Cells were incubated with chemokines in 100 mL sorbitol
buffer as described above and diluted 1:2 in PBS containing 4%
propidium iodide, giving a final concentration of 2% (Calcio-
biochem/Merck, Nottingham, UK), incubated in the dark on
ice for 30 min, and analysed with BD FACSCalibur, FL-2
(488 nm).
Scanning Electron Microscopy
For scanning electron microscopy (SEM), one million cells,
treated and incubated as described above, were centrifuged at
1,5006g, resuspended in fixation solution, and added to poly-L-
lysine coated glass cover slips for 1 hour. The cover slip was
carefully washed three times in phosphate-buffered saline (PBS),
followed by incubation in 3 ml of fixation solution (4% formal-
dehyde and 2.5% glutaraldehyde in PBS) at room temperature for
12 hours. Fixed specimens were dehydrated for 10 min at each
step of an ascending ethanol series and dried to the critical point in
a Balzers critical point dryer in liquid carbon dioxide using
absolute ethanol as an intermediate solvent. Samples were
examined in a Jeol J-330 scanning electron microscope at an
acceleration voltage of 5 kV and a working distance of 10 mm.
Cells from the same incubation were cultured and counted on days
0–3.
Cytotoxicity Assays
Haemolytic properties of the chemokines were investigated in
citrate-blood, diluted 1:1 in phosphate-buffered saline (PBS). In
a v-bottom shaped 96-well plate, with 100 mL of diluted blood
in each well, two of the chemokines (10 and 20 mM of CCL28
and CCL3), and Triton X-100 (2% Sigma-Aldrich, St Louis) as
positive control, were incubated with careful rotation in 37uC
for 1 h. The plates were then centrifuged at 8006g for 10 min.
Haemoglobin release was measured from the supernatant
(removed to another plate) at 540 nm, and expressed as the
percentage of Triton X-induced haemolysis. [21].
Lactate dehydrogenase (LDH) assay was carried out on
HaCaT-cells to investigate if the chemokines, in the concentra-
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tions used for the screen on the promastigotes, would have
membrane-damaging properties on human keratinocytes. Ha-
CaT-cells were grown in 96-well plates (3000 cells/well) in
serum-free keratinocyte medium (SFM) supplemented with
bovine pituitary extract and recombinant epidermal growth
factor (BPE-rEGF) (Invitrogen) to confluence. The medium was
removed, and 100 mL of 10/20 mM of CCL3/CCL28 in PBS
was added in triplicate wells of the plate. The LDH-based
TOX-7 kit (Sigma Aldrich, St Louis, MO) was used for
quantification of LDH release from the cells, as a measurement
of membrane damage to the cells. Triton X-100 (1%) was used
as positive control, and LDH release expressed as percent of
positive control. [21].
Supporting Information
Figure S1 Optical density in MTT assay corresponds to
the number of viable promastigotes. Promastigotes in
a dilution series were used in the MTT assay, to confirm that
absorbance correlates with the number of viable cells under the
assay conditions.
(TIFF)
Figure S2 Activity of chemokines against Leishmania
promastigotes in the presence of serum. MTT-assays
performed for all chemokines tested in sorbitol buffer (empty
columns), compared with sorbitol buffer containing 10% of human
serum (filled columns), showing decreased activity of several of the
chemokines in the presence of serum. Data shown are mean values
of duplicate experiments, in which the activity in sorbitol buffer
alone correspond to previous results.
(TIFF)
Figure S3 Activity of chemokines against Leishmania
promastigotes in salt-containing buffer, with or without
serum. MTT-assays performed for all screened chemokines in
HBSS (empty columns), compared with HBSS containing 10% of
human serum (filled columns), showing little activity of any of the
chemokines in the presence of higher salt-concentrations. CXCL6,
CXCL10, CCL20 and CCL28 seem to be more active in the
presence of both salt and serum, than in HBSS alone. Data shown
are mean values of duplicate assays.
(TIFF)
Table S1 In pilot studies, cells were prepared as described for
the MTT-assay, incubated with chemokines in 27uC for 2 h, after
which 50 mL of the incubation was transferred to 10 mL of culture
medium (previously described), and counted manually in a Neu-
bauer chamber day 0–3. Reactions were carried out in duplicate,
and are expressed as actual numbers. The pilot studies pointed
towards a differential cell survival, corresponding to reduction of
mitochondrial activity later observed in MTT-assays (Fig. 1).
Concentrations used were Amphotericin B (5 mM), chemokines
(10 mM), and Saponin (1%).
(TIF)
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